SavedAdd your journal

Journals / İzmir Atatürk Eğitim Hastanesi Tıp Dergisi / 2008 / Cilt: 46 - Sayı: 2

Peak bone mass and oral contraceptives

Doruk kemik kütlesi ve doğum kontrol hapları

Hakan YETİMALAR
Atilla KÖKSAL
Külal ÇUKUROVA
Çiğdem YILDIZ
Hüseyin İVİT
Adnan KEKLİK
Aşkın YILDIZ
Pages
57–60
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We tried to show the relation between oral contraceptives and peak bone mass.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Peak bone mass is the maximal level of bone density.
📊
Key Findings & Data:Peak bone mass is reached between 17-35 years.
💡
Conclusion & Impact:We tried to show the relation between oral contraceptives and peak bone mass.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Peak bone mass is the maximal level of bone density. This level is important for determination of the anticipated bone mass and fracture risk. Peak bone mass is reached between 17-35 years. Recent investigations show that the use of oral contraceptives in the reproductive period has a positive effect on peak bone mass and bone density. We tried to show the relation between oral contraceptives and peak bone mass.

Özet

Doruk kemik kütlesi büyüme ile erişilebilen en yüksek kemik kütlesi seviye-sidir ve daha sonra gelişecek kemik kaybını ve kırık riskini tayin etmek için önemlidir. Doruk kemik kütlesine erişme yaşı, en erken 17-18, en geç 35 olarak belirlenmiştir. Bazı yeni çalışmalar kadınların üreme dönemleri sırasında doğum kontrol hapı kullanımlarının kemik mineral yoğunluğu ve doruk kemik kütlesi üzerine pozitif etkili olduğunu göstermektedir. Bu derleme, doruk kemik kütlesi ve doğum kontrol hapları arasındaki ilişkiyi incelemek üzere planlandı.

🔖

Cite This Article

YETİMALAR, H., KÖKSAL, A., ÇUKUROVA, K., YILDIZ, Ç., İVİT, H., KEKLİK, A., YILDIZ, A. (2022). Peak bone mass and oral contraceptives. İzmir Atatürk Eğitim Hastanesi Tıp Dergisi, Cilt: 46 - Sayı: 2, 57–60. https://ajindex.com/articles/557535

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sarıdoğan ME. Editör: Kutsal YG. Modern Tıp Seminerleri: 19. Osteoporoz Epidemiyolojisi. Güneş Kitabevi, Ankara, Türkiye 2001. p: 12-14
  2. Ertüngealp E, Seyisoğlu H. Menopoz ve Osteoporoz. 1992; 27:367-370
  3. Corson SL. Oral contraceptives for the prevention of osteoporosis. J Reprod Med. 1993 Dec; 38(12 suppl): 1015-20
  4. Guthrie JR, Dennerstein L, Wark JD. Risk factors for osteoporosis: A review. Medscape Womens Health. 2000 Jul-Aug; 5(4):E1
  5. Cromer BA. Bone mineral density in adolescent and young adult women on injectable or oral contraception. Curr Opin Obstet Gynecol. 2003 Oct; 15(5):353-7
  6. Bure DB, Yashikawa T, Teegarden D, Lyle R et al. Exercise and oral contraceptive use supress the normal age-related increase in bone mass and strength of the femoral neck in women 18-31 years of age. Bone 2000; 27:6, 855-863
  7. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA. 1992 Nov 4; 268(17):2403-8
  8. Karck U, Breckwoldt M. Low-dose oral contraception and bone density. Ther Umsch. 2001 Sep; 58(9):547-51
  9. Polatti F, Perotti F, Filippa N, Gallina D, Nappi RE. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995 Apr; 51(4): 221-4
  10. Hewker GA, Forsmo S, Cadarette SM, Schei B, Jaglal SB, Forsen L et al. Correlates of forearm bone mineral density in young Norwegian women: The Nord-Trondelag Healt Study. Am J Epidemiol. 2002 Sep 1;56(5):418-27
  11. Sultana S, Choudhury S, Choudhury SA. Serum alkaline phosphatase and bone mineral density: to assess bone loss in oral contraceptive pill user. Mymensingh Med J. 2002 Jul; 11(2):107-9
  12. Williams JK. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach. Int J Fertil Womens Med. 2000 May-Jun; 45(3): 241-7
  13. Karck U, Breckwoldt M. Low-dose oral contraception and bone density. Fortschr Med. 2001 Feb 1;143(5):12.